American Century Companies’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-18,497
Closed -$1.15M 1416
2015
Q4
$1.15M Sell
18,497
-53
-0.3% -$3.73K ﹤0.01% 1099
2015
Q3
$1.24M Sell
18,550
-39,988
-68% -$3.26M ﹤0.01% 1083
2015
Q2
$5.7M Buy
58,538
+13,123
+29% +$1.25M 0.01% 799
2015
Q1
$4.25M Buy
45,415
+25,783
+131% +$2.19M ﹤0.01% 893
2014
Q4
$1.75M Buy
+19,632
New +$1.43M ﹤0.01% 1109

Other funds holding MACK

American Century Companies's MACK Position: Q1 2016 in Review

American Century Companies sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2016, closing a stake of 18,497 shares — an estimated $1.15M sold.

American Century Companies first reported a position in MACK in Q4 2014 and held it in 5 quarters. The position peaked at $5.7M in Q2 2015. 139 funds tracked by Wall St. Rank hold MACK as of Q1 2016.

  • American Century Companies reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • American Century Companies sold 18,497 Merrimack Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.15M.
  • American Century Companies first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
  • American Century Companies's Merrimack Pharmaceuticals, Inc. position peaked at $5.7M in Q2 2015.
  • 139 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2016.

Based on American Century Companies's 13F filing for Q1 2016, filed 2 May 2016.